Skip to main content

Table 1 Characteristics of participants: IHHP program

From: The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program

 

Interventional area

reference area

 

Before (N = 6175)

After (N = 4719)

P-value

Before (N = 6339)

After (N = 4853)

P-value

Age year (mean±SD)

38.61 ± 14.72

38.54 ± 15.27

0.83

39.17 ± 15.12

39.03 ± 15.85

0.64

Sex

Male

48.7%

49.3%

 

49.2%

50.7%

 
 

Female

51.3%

50.7%

0.51

50.8%

49.3%

0.12

BMI (kg/m 1)

<25

45.7%

44.5%

 

53.1%

49.4%

 
 

25-<29.9

35.4%

37.0%

0.23

32.6%

34.9%

0.001

 

30

18.9%

18.5%

 

14.3%

15.6%

 

Diabetes mellitus

6.3%

7.1%

0.09

4.9%

6.5%

<0.001

Prevalence of hypertension

base on DM(2)

20.5%

19.6%

0.24

17.4%

19.6%

0.003

Prevalence of hypertension(3)

18.9%

17.8%

0.14

15.7%

17.9%

0.002

Mean systolic blood pressure

116.13 ± 19.37

112.92 ± 18.27

<0.001

115.22 ± 18.96

114.79 ± 19.62

0.24

Mean diastolic blood pressure

74.79 ± 11.93

74.43 ± 11.06

0.11

76.18 ± 10.22

73.54 ± 11.03

<0.001

  1. 1) Body mass index (kg/m2)
  2. 2) BP ≥ 140/90 in nondiabetic BP ≥ 130/90 in diabetic patient
  3. 3) BP ≥ 140/90 in diabetic & nondiabetic patient